These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 24078689)

  • 1. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
    David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
    J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.
    Winter CC; Gumperz JE; Parham P; Long EO; Wagtmann N
    J Immunol; 1998 Jul; 161(2):571-7. PubMed ID: 9670929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
    Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
    J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals.
    Legrand N; David G; Rodallec A; Gaultier A; Salmon D; Cesbron A; Wittkop L; Raffi F; Gendzekhadze K; Retière C; Allavena C; Gagne K
    Clin Exp Immunol; 2021 Apr; 204(1):107-124. PubMed ID: 33314121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies.
    David G; Morvan M; Gagne K; Kerdudou N; Willem C; Devys A; Bonneville M; Folléa G; Bignon JD; Retière C
    Immunology; 2009 Oct; 128(2):172-84. PubMed ID: 19740374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells.
    Sim MJ; Stowell J; Sergeant R; Altmann DM; Long EO; Boyton RJ
    Eur J Immunol; 2016 Jan; 46(1):185-91. PubMed ID: 26467237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplified NKG2C+ NK cells in cytomegalovirus (CMV) infection preferentially express killer cell Ig-like receptor 2DL: functional impact in controlling CMV-infected dendritic cells.
    Djaoud Z; David G; Bressollette C; Willem C; Rettman P; Gagne K; Legrand N; Mehlal S; Cesbron A; Imbert-Marcille BM; Retière C
    J Immunol; 2013 Sep; 191(5):2708-16. PubMed ID: 23918974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined genotypic and phenotypic killer cell Ig-like receptor analyses reveal KIR2DL3 alleles displaying unexpected monoclonal antibody reactivity: identification of the amino acid residues critical for staining.
    Falco M; Romeo E; Marcenaro S; Martini S; Vitale M; Bottino C; Mingari MC; Moretta L; Moretta A; Pende D
    J Immunol; 2010 Jul; 185(1):433-41. PubMed ID: 20525888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.
    Borgerding A; Hasenkamp J; Engelke M; Burkhart N; Trümper L; Wienands J; Glass B
    Exp Hematol; 2010 Mar; 38(3):213-21. PubMed ID: 20056126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition.
    Schönberg K; Sribar M; Enczmann J; Fischer JC; Uhrberg M
    Blood; 2011 Jan; 117(1):98-107. PubMed ID: 20935255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resurrecting KIR2DP1: A Key Intermediate in the Evolution of Human Inhibitory NK Cell Receptors That Recognize HLA-C.
    Hilton HG; Blokhuis JH; Guethlein LA; Norman PJ; Parham P
    J Immunol; 2017 Mar; 198(5):1961-1973. PubMed ID: 28122963
    [No Abstract]   [Full Text] [Related]  

  • 12. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals.
    Foley B; De Santis D; Lathbury L; Christiansen F; Witt C
    Int Immunol; 2008 Apr; 20(4):555-63. PubMed ID: 18308713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergences in KIR2D+ natural killer and KIR2D+CD8+ T-cell reconstitution following liver transplantation.
    López-Álvarez MR; Campillo JA; Legaz I; Blanco-García RM; Salgado-Cecilia G; Bolarín JM; Gimeno L; Gil J; García-Alonso AM; Muro M; Alvarez-López MR; Miras M; Minguela A
    Hum Immunol; 2011 Mar; 72(3):229-37. PubMed ID: 21215286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.
    Moesta AK; Norman PJ; Yawata M; Yawata N; Gleimer M; Parham P
    J Immunol; 2008 Mar; 180(6):3969-79. PubMed ID: 18322206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.
    Hilton HG; Vago L; Older Aguilar AM; Moesta AK; Graef T; Abi-Rached L; Norman PJ; Guethlein LA; Fleischhauer K; Parham P
    J Immunol; 2012 Aug; 189(3):1418-30. PubMed ID: 22772445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells.
    Cognet C; Farnarier C; Gauthier L; Frassati C; André P; Magérus-Chatinet A; Anfossi N; Rieux-Laucat F; Vivier E; Schleinitz N
    Clin Immunol; 2010 Apr; 135(1):26-32. PubMed ID: 20093094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
    Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased frequency and function of KIR2DL1-3⁺ NK cells in primary HIV-1 infection are determined by HLA-C group haplotypes.
    Körner C; Granoff ME; Amero MA; Sirignano MN; Vaidya SA; Jost S; Allen TM; Rosenberg ES; Altfeld M
    Eur J Immunol; 2014 Oct; 44(10):2938-48. PubMed ID: 25043727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles.
    Martin MP; Nelson G; Lee JH; Pellett F; Gao X; Wade J; Wilson MJ; Trowsdale J; Gladman D; Carrington M
    J Immunol; 2002 Sep; 169(6):2818-22. PubMed ID: 12218090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
    Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM
    Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.